FDA Adverse Event Injury Summary report: N

ASR UNI FEMORAL IMPL SIZE 49

MDR report key: 2924654 · Received January 22, 2013

Report

Report Number
1818910-2013-02178
Event Type
Injury
Date Received
January 22, 2013
Report Date
September 7, 2011
Manufacturer
DEPUY INTERNATIONAL
Product Code
KWA
PMA / PMN Number
K040627
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED. NOT RETURNED.

Additional Manufacturer Narrative · 1

THERE IS NO NEW INFORMATION THAT WOULD CHANGE THE OUTCOME OF THE INVESTIGATION. THE COMPLAINT IS CONSIDERED CLOSED.

Description of Event or Problem · 1

LITIGATION PAPERS ALLEGE THAT SINCE COMPLETION OF THE HIP REPLACEMENT SURGERY, THE PATIENT HAS SUFFERED FROM INJURIES OF A PERMANENT, LASTING AND PAINFUL NATURE. IT IS FURTHER ALLEGED THE PATIENT'S ABILITY TO PERFORM NORMAL AND ENJOY REGULAR ACTIVITIES HAS BEEN IMPAIRED. THE PATIENT'S ABILITY TO PERFORM NORMAL AND ENJOY REGULAR ACTIVITIES HAS BEEN IMPAIRED AND THE PATIENT HAS BEEN TOLD THAT A REVISION IS NECESSARY TO REMOVE THE DEVICE. **UPDATE** (B)(6) 2011 - PLAINTIFF'S PRELIMINARY DISCLOSURE FORM WAS RECEIVED, WHICH IDENTIFIED PART/LOT INFORMATION. THE COMPLAINT AND ASSOCIATED MDRS WERE UPDATED. THERE WAS NO NEW INFORMATION THAT WOULD CHANGE THE OUTCOME OF THE INVESTIGATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
31035 ASR UNI FEMORAL IMPL SIZE 49 FEMORAL HEAD KWA DEPUY INTERNATIONAL 2118786

Patients

Seq Age Sex Outcome Treatment
1 Other